Unknown

Dataset Information

0

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.


ABSTRACT: Intestinal microbiota mediate toxicity of irinotecan (CPT-11) cancer therapies and cause systemic infection after CPT-11-induced loss of barrier function. The intestinal microbiota and their functions are thus potential targets for treatment to mitigate CPT-11 toxicity. However, microbiota changes during CPT-11 therapy remain poorly described. This study analysed changes in intestinal microbiota induced by CPT-11 chemotherapy. Qualitative and quantitative taxonomic analyses, and functional analyses were combined to characterize intestinal microbiota during CPT-11-based chemotherapy, and in presence or absence of oral glutamine, a treatment known to reduce CPT-11 toxicity. In the first set of experiments tumour-bearing rats received a dose-intensive CPT-11 regimen (125 mg kg(-1)×3 days), with or without oral glutamine bolus (0.75 g kg(-1)). In a subsequent more clinically-oriented chemotherapy regimen, rats received two cycles of CPT-11 (50 mg kg(-1)) followed by 5-flurouracil (50 mg kg(-1)). The analysis of fecal samples over time demonstrated that tumours changed the composition of intestinal microbiota, increasing the abundance of clostrridial clusters I, XI, and Enterobacteriaceae. CPT-11 chemotherapy increased cecal Clostridium cluster XI and Enterobacteriaceae, particularly after the dose-intensive therapy. Glutamine treatment prevented the reduced abundance of major bacterial groups after CPT-11 administration; i.e. total bacteria, Clostridium cluster VI, and the Bacteroides-group. Virulence factor/toxin genes of pathogenic Escherichia coli and Clostridium difficile were not detected in the cecal microbiota. In conclusion, both colon cancer implantation and CPT-11-based chemotherapies disrupted the intestinal microbiota. Oral glutamine partially mitigated CPT-11 toxicity and induced temporary changes of the intestinal microbiota.

SUBMITTER: Lin XB 

PROVIDER: S-EPMC3406026 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

Lin Xiaoxi B XB   Dieleman Levinus A LA   Ketabi Ali A   Bibova Ilona I   Sawyer Michael B MB   Xue Hongyu H   Field Catherine J CJ   Baracos Vickie E VE   Gänzle Michael G MG  

PloS one 20120726 7


Intestinal microbiota mediate toxicity of irinotecan (CPT-11) cancer therapies and cause systemic infection after CPT-11-induced loss of barrier function. The intestinal microbiota and their functions are thus potential targets for treatment to mitigate CPT-11 toxicity. However, microbiota changes during CPT-11 therapy remain poorly described. This study analysed changes in intestinal microbiota induced by CPT-11 chemotherapy. Qualitative and quantitative taxonomic analyses, and functional analy  ...[more]

Similar Datasets

| S-EPMC3839688 | biostudies-literature
| S-EPMC2696758 | biostudies-other
| S-EPMC4718832 | biostudies-literature
| S-EPMC2780016 | biostudies-literature
2017-06-17 | E-MTAB-5184 | biostudies-arrayexpress
| S-EPMC4323000 | biostudies-literature
| S-EPMC10121581 | biostudies-literature
2008-01-26 | E-TABM-211 | biostudies-arrayexpress
| S-EPMC4029760 | biostudies-literature
| S-EPMC8230279 | biostudies-literature